Repligen | RGEN - 债务

金融业

USD

USD 2.93B

现金及等价物

USD 582.65M

USD 85.97M

USD 1.16B

USD 126.21M

USD 546.59M

USD 19.98M

USD 40.01M

1.78K

EPS每股收益

USD 0.48

股本和储备

USD 2.11B

USD 108.28M

债务利息支出

USD 5.58M

USD 7.31M

USD 546.59M

USD 6.32B

USD 8.33M

USD 174.27M

USD 19.98M

普通股股本

USD 56.4M

109.48

USD 19.11M

USD 194M

销售和管理费用

USD 76.54M

USD 179.26M

贸易债权人

USD 34.66M

应收帐款人

USD 151.55M

	债务	更改		日
Agilent	USD 3.35B		55M	2025-09
Align Technology	USD 114.45M		6.82M	2025-12
Bio Techne	USD 200M		60M	2026-03
BioMarin Pharmaceutical	USD 1.44B		833.74M	2026-03
Bristol-Myers Squibb	USD 47.14B		3.9B	2025-12
Bruker	USD 2.04B		34.4M	2025-12
Charles River Laboratories	USD 2.57B		58.23M	2025-12
Danaher	USD 18.48B		66M	2026-03
Dentsply International	USD 2.33B		137M	2026-03
General Electric Aerospace	USD 20.28B		217M	2026-03
Henry Schein	USD 3.75B		313M	2026-03
Illumina	USD 2.55B		23M	2025-12
IQVIA Holdings	USD 15.83B		109M	2026-03
Mettler Toledo International	USD 2.15B		57.69M	2025-12
Myriad Genetics	USD 59.3M		19.7M	2025-03
OraSure Technologies	USD 782K		465K	2024-06
Pacific Biosciences Of California	USD 892.24M		653K	2023-12
Pfizer	USD 63.73B		231M	2026-03
Repligen	USD 546.58M		4.37M	2026-03
Revvity	USD 3.4B		29.2M	2025-12
Standard Biotools	USD 27.39M		1.23M	2025-09
Thermo Fisher Scientific	USD 39.39B		3.7B	2025-12
Waters	USD 1.49B		4.92M	2025-12
West Pharmaceutical Services	USD 202.8M		0	2026-03